Related Experiment Video

Updated: Jun 3, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina

Gjin Ndrepepa1, Siegmund Braun, Stefanie Schulz

  • 1Deutsches Herzzentrum, Technische Universität, Munich, Germany. ndrepepa@dhm.mhn.de

European Journal of Clinical Investigation
|March 19, 2011
PubMed

Insights

Combining high-sensitivity cardiac troponin (hs-TnT) and N-terminal probrain natriuretic peptide (NT-proBNP) significantly enhances mortality prediction in stable coronary artery disease patients. This dual biomarker approach offers improved long-term risk assessment for better patient outcomes.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Clinical Risk Stratification

Background:

  • High-sensitivity cardiac troponin (hs-TnT) and N-terminal probrain natriuretic peptide (NT-proBNP) are established mortality predictors in stable coronary artery disease (CAD).
  • The synergistic effect of combining hs-TnT and NT-proBNP for enhanced mortality prediction in stable CAD remains under investigation.

Purpose of the Study:

  • To evaluate the combined prognostic value of hs-TnT and NT-proBNP in predicting long-term mortality.
  • To determine if dual biomarker assessment improves risk stratification beyond individual markers in patients with stable coronary artery disease.

Main Methods:

  • A cohort of 869 patients with stable coronary artery disease post-percutaneous coronary intervention were analyzed.
  • Hs-TnT and NT-proBNP levels were measured pre-angiography and dichotomized using median cut-off values.
  • Patients were categorized into four groups based on biomarker levels (low/low, low/high, high/low, high/high) to assess all-cause mortality over 4 years.

Main Results:

  • The high hs-TnT/high NT-proBNP group exhibited a significantly higher 4-year mortality rate (18.1%) compared to the low hs-TnT/low NT-proBNP group (2.5%).
  • The combined use of hs-TnT and NT-proBNP significantly increased the discriminatory power for mortality prediction.
  • Multivariable analysis demonstrated that including both biomarkers improved the model's predictive accuracy (absolute and relative integrated discrimination improvement of 0.039 and 26.0%, respectively).

Conclusions:

  • The combined assessment of hs-TnT and NT-proBNP provides superior long-term mortality risk prediction in patients with stable coronary heart disease.
  • This dual biomarker strategy enhances clinical decision-making for risk stratification and management in stable CAD.
Abstract

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...